Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Dysregulation of Wnt signaling is known to be associated with various cancers. As such, identification of novel Wnt pathway targets in cancer and better characterization of already-known targets present exciting, emerging opportunities for cancer treatment. In this Special Issue, we feature papers which discuss the role of Wnt signaling and associated targets in cancer metabolism, tumor immune response, and tumor microenvironment. Papers discussing a range of Wnt-mediated cancers, including those of the colon, liver, pancreas, synovium, bladder, etc., are included.

Medicine --- Pharmacology --- Wnt signaling --- synovial sarcoma --- TNIK --- NCB-0846 --- MYC --- hepatitis B virus --- HBV --- cancer --- liver cancer --- β-catenin --- TCF/LEF --- pancreatic cancer --- pancreatic stellate cells --- CBP --- p300 --- pancreatitis --- fibrosis --- just-right signaling --- APC --- colorectal cancer --- RNA-binding proteins --- Musashi --- drug discovery --- Notch signaling --- cancer therapy --- fungi secondary metabolite derivative --- microenvironment --- Wnt --- AML --- drug target --- signaling --- colorectal --- porcupine --- R-spondin --- serrated --- immunotherapy --- wnt --- vitamin D --- colon cancer --- L1 --- Wnt target genes --- cell adhesion --- NF-κB --- invasion and metastasis --- cancer stem cells --- EMT --- Lgr5 --- Wnt/beta-catenin signaling --- angiogenesis --- anti-angiogenic therapy --- gastrointestinal cancers --- therapeutic targeting of Wnt signaling --- β-catenin paradox --- molecular targeting --- urothelial cancer --- immune checkpoint inhibitor --- immunotherapy resistance --- IBD --- colitis --- β-catenin mutations --- tumor metabolism --- tumor immunology --- molecular therapeutics --- precision medicine --- astrocytic brain tumors --- DKKs --- GSK3β

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The scientific community has made significant progress in our molecular understanding of sporadic and hereditary colorectal carcinogenesis and progression. Thie pertains to, e.g., the discovery of (mutated) oncogenes and tumor suppressor genes, microsatellite instabilities, modifications in DNA repair, cellular aging, signaling cascades, genomic, epigenetic, transcriptional, translational, and protein modifications, as well as microbiotic factors and further parameters. Progression and metastasis have been more intensively studied, especially during recent years, leading to an intensified knowledge on molecular protagonists and microenvironmental interactions contributing to invasion, dissemination, and metastasis; still, more concerted efforts need to be made to better understand issues such as metastasis to different sites or the metastatic heterogeneity of single cells. Nevertheless, based on actual discoveries, personalized medicine, together with highly interdisciplinary therapeutic strategies combining advanced levels of surgical techniques, oncology, and radiation in neoadjuvant, adjuvant, or palliative settings, has started to improve the clinical prognosis of individual patients with colorectal cancer. The present Special Issue features articles of excellent international experts with the latest data in the fields mentioned. With this Special Issue, we aim to deepen discussions amongst colleagues in all kinds of disciplines working on this disease and to intensify interdisciplinary collaborations aimed at an ultimate understanding of strategies to defeat and prevent, colorectal cancer, and its progression.

Phage --- bacteriophages --- diet --- infection --- colorectal --- cancer --- nutrition --- circulating tumor cells --- colorectal cancer --- EPISPOT assay --- CellSearch® system --- predictive value --- chromatin density --- nanoscale --- tumour cell heterogeneity --- microRNAs --- metastasis --- super-resolution microscopy --- early onset --- cohort --- epidemiology --- liquid biopsy --- biomarker --- indirect carcinogenesis --- bovine meat and milk factors (BMMF) --- chronic zoonosis --- multiplex --- tumor immunology --- immune landscape --- spontaneous feline intestinal tumors --- comparative oncology --- tumor budding --- CTNNB1 --- genome-wide methylation array --- methylation --- miRNA --- colon cancer --- personalized treatment --- drug combinations --- Matrix Metalloproteinases (MMPs) --- polyp --- TIMPs --- MMP polymorphisms --- MMP targeting --- S100A4 --- DKK1 --- Wnt signaling --- patient survival --- gender --- rectal cancer --- radiochemotherapy --- radiosensitivity --- DNA double-strand breaks --- deposited energy --- quality of life --- blood values --- (molecular) carcinogenesis --- cancer progression --- (single) cancer cell heterogeneity --- models --- infectious agents --- (targeted) therapy --- personalized medicine

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The scientific community has made significant progress in our molecular understanding of sporadic and hereditary colorectal carcinogenesis and progression. Thie pertains to, e.g., the discovery of (mutated) oncogenes and tumor suppressor genes, microsatellite instabilities, modifications in DNA repair, cellular aging, signaling cascades, genomic, epigenetic, transcriptional, translational, and protein modifications, as well as microbiotic factors and further parameters. Progression and metastasis have been more intensively studied, especially during recent years, leading to an intensified knowledge on molecular protagonists and microenvironmental interactions contributing to invasion, dissemination, and metastasis; still, more concerted efforts need to be made to better understand issues such as metastasis to different sites or the metastatic heterogeneity of single cells. Nevertheless, based on actual discoveries, personalized medicine, together with highly interdisciplinary therapeutic strategies combining advanced levels of surgical techniques, oncology, and radiation in neoadjuvant, adjuvant, or palliative settings, has started to improve the clinical prognosis of individual patients with colorectal cancer. The present Special Issue features articles of excellent international experts with the latest data in the fields mentioned. With this Special Issue, we aim to deepen discussions amongst colleagues in all kinds of disciplines working on this disease and to intensify interdisciplinary collaborations aimed at an ultimate understanding of strategies to defeat and prevent, colorectal cancer, and its progression.

Medicine --- Oncology --- Phage --- bacteriophages --- diet --- infection --- colorectal --- cancer --- nutrition --- circulating tumor cells --- colorectal cancer --- EPISPOT assay --- CellSearch® system --- predictive value --- chromatin density --- nanoscale --- tumour cell heterogeneity --- microRNAs --- metastasis --- super-resolution microscopy --- early onset --- cohort --- epidemiology --- liquid biopsy --- biomarker --- indirect carcinogenesis --- bovine meat and milk factors (BMMF) --- chronic zoonosis --- multiplex --- tumor immunology --- immune landscape --- spontaneous feline intestinal tumors --- comparative oncology --- tumor budding --- CTNNB1 --- genome-wide methylation array --- methylation --- miRNA --- colon cancer --- personalized treatment --- drug combinations --- Matrix Metalloproteinases (MMPs) --- polyp --- TIMPs --- MMP polymorphisms --- MMP targeting --- S100A4 --- DKK1 --- Wnt signaling --- patient survival --- gender --- rectal cancer --- radiochemotherapy --- radiosensitivity --- DNA double-strand breaks --- deposited energy --- quality of life --- blood values --- (molecular) carcinogenesis --- cancer progression --- (single) cancer cell heterogeneity --- models --- infectious agents --- (targeted) therapy --- personalized medicine

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book—entitled “Mechanisms and Novel Therapeutic Approaches for Gynecologic Cancer”—was edited as a Special Issue of Biomedicines, focusing on basic research such as genomics, epigenomics, and proteomics, as well as clinical research in the field of gynecologic oncology. The number of patients with gynecological cancer has been increasing worldwide due to its high lethality and lack of early detection tools and effective therapeutic interventions. In this regard, basic research on its pathophysiology and novel molecular targeting intervention is required to improve the prognosis of gynecologic cancer. This book contains 13 papers, including 8 original research papers and 5 reviews focusing on the basic research of gynecologic oncology. The reader can learn about state-of-the-art research and obtain extensive knowledge of the current advances in the field of gynecologic oncology. It is my hope that this book contributes towards the progress of gynecologic oncology.

nucleus accumbens-associated protein 1 (NAC1) --- BEN (BANP, E5R and NAC1) domain --- sequence-specific DNA-binding protein --- solution NMR structure --- isothermal titration calorimetry (ITC) --- human cytomegalovirus --- ovarian cancer --- cancer progression --- inflammation --- immunosuppression --- endometrial carcinoma --- immune micro-environment --- immune checkpoints inhibitors --- microsatellite instability --- mismatch repair deficiency --- platelet-activating factor acetylhydrolase (PAF-AH --- PLA2G7) --- BRCA1 mutant ovarian cancer --- Wnt signaling --- pGSK3β --- β-catenin --- prognosis --- vulvar melanoma --- vaginal melanoma --- targeted therapy --- gynecological cancer --- melanoma treatment --- gene ontology --- epithelial ovarian cancers --- borderline ovarian tumors --- differentially expressed genes --- aryl hydrocarbon receptor --- epithelial–mesenchymal transition --- integrative analysis --- testin --- p16 protein --- cervical cancer --- cervical neoplasia --- immunohistochemistry --- chimeric antigen receptor --- CD44 --- adoptive immunotherapy --- NK cells --- epithelial ovarian cancer --- DNA damage response --- somatic mutation --- clear cell carcinoma --- endometrioid endometrial cancer --- DNA mismatch repair (MMR) --- MMR deficient (dMMR) --- long-term survival --- exosome --- miRNA --- biomarkers --- liquid biopsy --- interventional radiotherapy --- vaginal-cuff brachytherapy --- HDR brachytherapy --- in vivo dosimetry --- endometrial cancer --- biological planning --- drug repurposing --- non-coding RNAs --- nanocarriers --- anti-angiogenic therapy --- n/a --- epithelial-mesenchymal transition

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The Book covers this whole field, from the discovery of structurally new and bioactive natural products (including biomacromolecules), from marine macro-/micro-organisms, to the pharmacodynamics, pharmacokinetics, metabolisms, and mechanisms of marine-derived lead compounds, both in vitro and in vivo, along with the synthesis and/or structural optimization of marine-derived lead compounds and their structure–activity relationships. Taken together, this Special Issue reprint not only provides inspiration for the discovery of marine-derived novel bioactive compounds, but also sheds light on the further research and development of marine candidate drugs.

Antarctic krill (Euphausia superba) --- peptide --- antioxidant activity --- stability --- oyster --- plasma --- peptidome --- antimicrobial peptides --- cytotoxicity --- actinomycete --- piericidins --- absolute configuration --- Pestalotiopsis heterocornis --- heterocornols --- anti-inflammatory activity --- sponge-derived fungus --- sclerotides --- lipodepsipeptide --- Aspergillus sclerotiorum --- nasopharyngeal carcinoma --- AChE inhibitory --- vascular endothelial cell --- flavonoid --- oxidized low-density lipoprotein --- Nrf2 --- apoptosis --- butyrolactone I --- food allergy --- metabolism --- pharmacokinetics --- actinomycin X2 --- microbial pigments --- dyeing --- silk --- antibacterial properties --- PD-L1 --- virtual screening --- pharmacophore modeling --- ADME --- molecular dynamics --- xanthones --- ascidian-derived fungus --- Diaporthe sp. --- anti-glioma activity --- antiaging --- Sonneratia apetala --- signaling pathway --- Caenorhabditis elegans --- mutants --- coral-derived fungi --- Aspergillus hiratsukae --- meroterpenoids --- antibacterial activity --- cytotoxic activity --- deep-sea-derived fungus --- Aspergillus puniceus --- isoquinoline alkaloid --- protein tyrosine phosphatase inhibitor --- antibacterial --- Aspergillus sp. --- geodin --- semisynthesize --- insecticidal activity --- Arca inflata --- antitumor peptide --- MAPK signaling --- calmodulin --- colorectal cancer --- methicillin-resistant Staphylococcus aureus --- actinomycin D --- Streptomyces parvulus --- mechanism --- mangrove endophytic Pestalotiopsis --- Sdy-1 --- antitumor activity --- Wnt signaling --- β-catenin --- eremophilane sesquiterpenoids --- mangrove-derived fungus --- Penicillium sp. --- Oceanapia --- sponge --- secondary metabolites --- biological activities --- drug design --- anticancer --- cyclic pentapeptide --- galaxamide analogues --- skipjack tuna (Katsuwonus pelamis) muscle --- angiotensin-I-converting enzyme (ACE) peptide --- molecular docking --- nitric oxide (NO) --- endothelin-1 (ET-1) --- Trichoderma longibrachiatum --- sesquiterpene glycoside --- antimicrobial activity --- marine fungi --- Aspergillus unguis --- depsides --- depsidones --- osteoclast differentiation --- soft-coral-derived fungus --- pyranodipyran derivatives --- tyrosyl DNA phosphodiesterase 1 inhibitory activities --- fluorescent properties --- butenolides --- enantiomers --- Aspergillus terreus --- pancreatic lipase --- NAFLD --- fucoxanthin --- adenosine monophosphate-activated protein kinase (AMPK) --- nuclear factor erythroid-2-related factor 2-mediated (Nrf2) --- Toll-like receptor 4-mediated (TLR4) --- Aspergillus flavipes HN4-13 --- emodin --- macroporous resin XAD-16 --- adsorption kinetics and isotherms --- enrichment --- tetramic acid derivatives --- deep-sea fungus --- clavipitacae --- Lecanicillium fusisporum --- chronic kidney disease --- fucoidan --- cognitive dysfunction --- neuroinflammation --- oxidative stress --- GSK3β-Nrf2-HO-1 signaling --- microglial polarization --- deep-sea actinomycetes --- aromatic acids --- oximes --- antihyperlipidemic --- phycocyanin --- microbiota --- transcriptome --- IL-17 pathway --- Hahella --- prodiginine --- chejuenlide --- genome mining --- LC-MS/MS --- CDK4/6 --- marine compounds --- pharmacophore construction --- ADMET --- mm-pbsa